Samsung BioLogics inks manufacturing deal for coronavirus treatment
SEOUL, April 10 (Yonhap) -- Samsung BioLogics, a biopharmaceutical unit of South Korea's Samsung Group, said Friday that it has clinched a US$362 million deal to manufacture a candidate treatment for the novel coronavirus.
Under the deal, Samsung BioLogics will start full-scale production of U.S. drug firm Vir Biotechnology's candidate COVID-19 treatment that is known to be very powerful in neutralizing the virus.
Samsung Biologics will begin manufacturing as early as October with the first engineering run, with potential commercial batches to be manufactured at its third plant starting in 2021.
Vir Biotechnology, a bioscience company based in San Francisco, specializes in developing infectious disease treatment drugs. The company is currently developing a single clone antibody for COVID-19 treatment by separating antibodies from those completely cured from severe acute respiratory syndrome (SARS).
"Vir's candidate molecules supported by Samsung BioLogics' production scale have the potential to bring hope to countless lives across nations suffering from COVID-19," CEO Kim Tae-han said in a press release.
The number of confirmed cases of COVID-19 has reached nearly 1.6 million globally, according to data collected by Johns Hopkins University. Currently, there is no cure for the illness.
khj@yna.co.kr
(END)
-
New BTS song 'Film Out' tops Japan's Oricon weekly chart
-
'Dynamite' becomes 3rd BTS video to top 1 bln views
-
S. Korea, U.S. authorities assess N.K. has completed building new 3,000-ton submarine: sources
-
Mamamoo to hold online concert on British streaming platform next month
-
'Fake Love' becomes 4th BTS video to top 900 mln views
-
(Yonhap Feature) How young voters, once solid supporters of liberal causes, turned against Moon's party in by-elections
-
From Rose to Baekhyun, K-pop group idols also shine as solo acts
-
Moon takes election rout as 'reprimand' from the public, Cheong Wa Dae says
-
Boy band TXT to perform on Ellen DeGeneres show in latest global push
-
BTS to stream concerts in weekend Bang Bang Con event
-
S. Korea voices 'grave concerns' over Japan's expected decision to release Fukushima water into sea
-
Sex doll experience cafe condemned by residents in Yongin
-
(LEAD) New virus cases under 600 for 2nd day; spring resurgence in store
-
S. Korea expresses 'strong regret' over Japan's decision to release water from Fukushima
-
(LEAD) Biden pledges more investment in meeting over semiconductor shortage